From illegal poison to legal medicine: A qualitative research in a heroin-prescription trial in Spain

Drug and Alcohol Review

Volumn 28, Issue 2, 2009, Pages 186-195

  Romo, Nuria ^a   Poo, Mónica ^b   Ballesta, Rosario ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b Andalusian Foundation for Drug Addiction Assistance   (Spain)

Author keywords

Chronic illness; Heavily addicted heroin users; Heroin assisted treatment; Heroin prescription trial; Qualitative research

Indexed keywords

DIAMORPHINE; METHADONE; NARCOTIC AGENT;

ADULT; ARTICLE; DRUG ADMINISTRATION; FEMALE; HEROIN DEPENDENCE; HUMAN; MALE; PRESCRIPTION; QUALITATIVE RESEARCH; SOCIAL SUPPORT; SPAIN; SUBSTANCE ABUSE;

ADULT; DRUG ADMINISTRATION SCHEDULE; DRUG PRESCRIPTIONS; FEMALE; HEROIN; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; NARCOTICS; QUALITATIVE RESEARCH; SOCIAL SUPPORT; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 67650648729     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2008.00015.x     Document Type: Article

References (43)

1. Gamella JF. Los heroinómanos de un barrio de Madrid: un estudio cuantitativo mediante métodos etnográficos. Antropología 1993;4-5:57-97.
2. Barrio G,De la Fuente L, Camí J. El consumo de drogas en Espana y su posición en el contexto europeo. Medicina Clínica 1993;101:344-55.
3. Buning E. La estrategia de 'educción de dań os' frente al SIDA entre los usuarios de drogas en Holanda. Adicciones 1995; 7:263-70.
4. McCusker C, Davies M. Prescribing drug of choice to illicit heroin users: the experience of a U.K. community drug team. J Subst Abuse Treat 1996;13:521-31.
5. Martínez González F. Redes y programas para el tratamiento de las drogodependencias. Revista De Estudios De Juventud 1997;40:79-93.
6. Poo M, Markez I, Etxegoien R, et al. Programa de mantenimiento con metadona en farmacias.Valoración tras un ano de funcionamiento en Bizkaia. Bizkaia: Colegio Oficial de Farmaceúticos de Bizkaia, 1997.
7. Arroyuelo O, Fernández de Garayalde A. Primer programa de intercambio de jeringuillas en el Estado Espań ol. JANO 1991;XL:119-24.
8. Insua P, Ubillos S, Romo Y. Programas de prevención de la trasmisión del SIDA en consumidores de drogas por vía parenteral. Vega A. Educación y SIDA: problemática y respuestas. San Sebastián: Universidad del País Vasco, 1993:171-88.
9. Soloeta I, Velasco MD. Programa de intercambio de jeringuillas en el centro penitenciario de Basauri. Edex Kolektiboa. Reducción de riesgos, hábitos de vida saludables, modificación de conductas de riesgo, cárcel, jeringuillas. Bilbao: Edex Kolektiboa, 1999.
10. Fischer B, Rehm J, Kirst M, et al. Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur J Public Health 2002;12:228-34.
11. Hartnoll RL, Micheson MC, Battersby A, et al. Evaluation of heroin maintenance in controlled trial. Arch Gen Psychiatry 1980;37:877-84.
12. Uchtenhagen A, Gutzwiller F, Dobler-Mikola A, Steffen T. Programme for a medical prescription of narcotics: a synthesis of results. Eur Addict Res 1997;3:160-63.
13. Steffen T, Christen S, Blättler R, Gutzwiller F. Infectious diseases and public health: risk-taking behavior during participation in the Swiss program for a medical prescription of narcotics (PROVE). Subst Use Misuse 2001;36:71-89.
14. Pernerger TV, Giner F, del Río M, et al. Randomized trial of heroin maintenance programme for addicts who fail in conventional drug treatment. BMJ 1998;317:13-18.
15. Van den Brink W, Hendriks VM, Blanken P, Koeter MWJ, Van Zwieten BJ, Van Ree JM. Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ 2003;327:310-12.
16. March JC, Oviedo-Joekes E, Perea-Milla E, Carrasco F. Controlled trial of prescribed heroin in the treatment of opioid addiction. J Subst Abuse Treat 2006;31:203-11.
17. Bourgois P. Anthropology and epidemiology on drugs: the challenges of cross-methodological and theoretical dialogue. Int J Drug Policy 2002;13:259-69.
18. Zador D. Injectable opiate maintenance in the UK: is it good clinical practice? Addiction 2001;96:547-53.
19. Satel SL, Aeschbach E. The Swiss heroin trial. Scientifically sound? J Subst Abuse Treat 1999;17:331-5.
20. Trujols J, Perez de los Cobos J. La perspectiva de los usuarios sobre los tratamientos de mantenimiento con metadona: una revisión centrada en la satisfacción con el tratamiento. Adicciones 2005;17:181-204.
21. Asadi-Lari M, Tamburini M, Gray D. Patients' needs, satisfaction, and health related quality of life: towards a comprehensive model. Health Qual Life Outcomes 2004;2:32.
22. Nichter M, Quintero G, Nichter M, Mock J, Shakib S. Qualitative research: contributions to the study of drug use, drug abuse, and drug use(r)-related interventions. Subst Use Misuse 2004;39:1907-69.
23. Lambert H, McKevitt C. Anthropology in health research: from qualitative methods to multidisciplinarity. BMJ 2002;325:210-13.
24. Maher L. Don't leave us this way: ethnography and injecting drug use in the age of AIDS. Int J Drug Policy 2002;13:311-25.
25. Glaser B, Strauss, A. The discovery of grounded theory 1967. Chicago, IL: Aldine, 1967.
26. Barbour RS. Checklist for improving rigour in qualitative research: a case of the tail wagging the dog? BMJ 2001;322:1115-17.
27. Gregory S. Living with chronic illness in the family setting. Sociol Health Illn 2005;27:372-92.
28. Bury M. The sociology of chronic illness: a review of research and prospects. Sociol Health Illn 1991;13:451-68.
29. Bell J, Dru A, Fischer B, Levit S, Sarfraz A. Substitution therapy for heroin addiction. Subst Use Misuse 2002;37:1149-78.
30. Gamella JF. Claves de razón práctica, ISSN 1130-3689, No. 72, 1997, pp 20-30.
31. Orr AS, Wynia MK. Ethics and heroin prescription: no more fuzzy goals! Am J Bioeth 2002;2:52-3.
32. Kelly MP, Field D. Medical sociology, chronic illness and the body. Sociol Health Illn 1996;18:241-57.
33. Fischer B, Chin AT, Kuo I, Kirst MA, Vlahov D. Canadian illicit opiate users' views on methadone and other opiate prescription treatment: an exploratory qualitative study. Subst Use Misuse 2002;37:495-522.
34. Adrian M. Whose needs are to be met? Customer satisfaction with delivery of treatment services for heroin users. Subst Use Misuse 2002;37:543-7.
35. Agar M, Bourgois P, French J, Murdoch O. Heroin addict habit size in three cities: context and variation. J Drug Issues 1998;28:921-40.
36. Sprumont D. Ethical evaluation of heroin-prescription research. An insider's view. Am J Bioeth 2002;2:63-4.
37. Wodak A. Methadone and heroin prescription: babies and bath water. Subst Use Misuse 2002;37:523-31.
38. Ribeaud D. Long-term impacts of the Swiss heroin prescription trials on crime of treated heroin users. J Drug Issues 2004;34:163-94.
39. Eland-Goossensen A, Hak T, Vollemans L. Heroin addiction careers: downward spiral or controlled descent? Contemp Drug Probl 1997;24:293-318.
40. Bury M. Chronic illness as biographical disruption. Sociol Health Illn 1982;4:167-82.
41. Gibson B, Acquah S, Robinson PG. Entangled identities and psychotropic substance use. Sociol Health Illn 2004;26:597-616.
42. Ruefli T, Rogers SJ. How do drug users define their progress in harm reduction programs? Qualitative research to develop user-generated outcomes. Harm Reduct J 2004;1:8.
43. Bourgois P. Disciplining addictions: the bio-politics of methadone and heroin in the United States. Cult Med Psychiat 2000;24:165-95.